Pfizer and the American Society of Gene + Cell Therapy (ASGCT): Gene and Gene-modified Cell Therapies Medical Education

Will focus on independent medical education initiatives that will result in the measurable improvement of the medical and scientific understanding of gene and gene-modified cell
therapies to help prepare multidisciplinary teams for the integration of gene and gene-modified cell therapies into the treatment armamentarium of eligible patients with a Rare Disease.

Funding: up to $50K

https://www.ra.trdf.co.il/files/GlobalGeneTxEducation.pdf